Категории

Dr. Coleman on the VELIA Trial Impact on Ovarian Cancer Practice

Опубликовано: 10 Март 2020
на канале: OncLive
5,699
16

Website: https://www.onclive.com
Twitter:   / onclive  
Facebook:   / onclive  
LinkedIn:   / onclive  

Смотрите видео Dr. Coleman on the VELIA Trial Impact on Ovarian Cancer Practice онлайн без регистрации, длительностью часов минут секунд в хорошем качестве. Это видео добавил пользователь OncLive 10 Март 2020, не забудьте поделиться им ссылкой с друзьями и знакомыми, на нашем сайте его посмотрели 5,699 раз и оно понравилось 16 людям.

play_arrow
156,647
1 тыс

الفنانة حنان شوقي: أنا محجبة.. مين قال إني مش محجبة؟

الفنانة حنان شوقي: أنا محجبة.. مين قال إني مش محجبة؟
play_arrow
291
9

Pescasub: ASPETTANDO LA REGINA

Pescasub: ASPETTANDO LA REGINA
play_arrow
98
8

🥹🥹🥹quien pasa navidad sólo 🥹

🥹🥹🥹quien pasa navidad sólo 🥹
play_arrow
480
9

Ограбление, мать твою! ))))

Ограбление, мать твою! ))))
play_arrow
15,871
217

Shopify Storefront Filtering (Online Store 2.0)

Shopify Storefront Filtering (Online Store 2.0)
play_arrow
17,940
8

full film izle - pislik - basitfilmizle.com

full film izle - pislik - basitfilmizle.com
play_arrow
644
5

Итальянский домашний кабинет Torriani avorio

Итальянский домашний кабинет Torriani avorio
play_arrow
3,333
37

2016 FORD F350 CREW LONG 6.7L POWERSTROKE DIESEL PLATINUM WALK AROUND REVIEW SOLD! 8875 SUMMITAUTO

2016 FORD F350 CREW LONG 6.7L POWERSTROKE DIESEL PLATINUM WALK AROUND REVIEW SOLD! 8875 SUMMITAUTO
Похожие видео
play_arrow
Precision Medicine in Metastatic Triple Negative Breast Cancer

Precision Medicine in Metastatic Triple Negative Breast Cancer
play_arrow
Treating Non–Small Cell Lung Cancer With an EGFR Exon 20 Insertion

Treating Non–Small Cell Lung Cancer With an EGFR Exon 20 Insertion
play_arrow
EGFR Exon 20 Mutations in Non–Small Cell Lung Cancer

EGFR Exon 20 Mutations in Non–Small Cell Lung Cancer
play_arrow
OncLive News Network On Location: ASCO 2020 Day 1

OncLive News Network On Location: ASCO 2020 Day 1
play_arrow
Diagnosis of Neurofibromatosis Type 1

Diagnosis of Neurofibromatosis Type 1
play_arrow
Dr. Lopes on the Rationale to Stop Immunotherapy After 2 Years in Lung Cancer

Dr. Lopes on the Rationale to Stop Immunotherapy After 2 Years in Lung Cancer
play_arrow
Novel Treatments in HER2-Positive Breast Cancer

Novel Treatments in HER2-Positive Breast Cancer
play_arrow
Lurbinectedin’s Role in Managing SCLC

Lurbinectedin’s Role in Managing SCLC
play_arrow
Dr. Rizvi on the Limitations of ABVD in Hodgkin Lymphoma

Dr. Rizvi on the Limitations of ABVD in Hodgkin Lymphoma
play_arrow
Therapy Options for Hepatitis B/C–Related HCC

Therapy Options for Hepatitis B/C–Related HCC
play_arrow
Treating Patients With Essential Thrombocytopenia

Treating Patients With Essential Thrombocytopenia
play_arrow
Biology of Clear Cell Renal Cell Carcinoma

Biology of Clear Cell Renal Cell Carcinoma
play_arrow
The Use of Ruxolitinib in Myelofibrosis

The Use of Ruxolitinib in Myelofibrosis
play_arrow
Current Treatment Landscape of Soft Tissue Sarcoma

Current Treatment Landscape of Soft Tissue Sarcoma
play_arrow
Diagnostic Testing Procedure for Soft Tissue Sarcoma

Diagnostic Testing Procedure for Soft Tissue Sarcoma
play_arrow
Treatment Landscape of Castrate-Resistant Prostate Cancer

Treatment Landscape of Castrate-Resistant Prostate Cancer
play_arrow
Lenalidomide in Del 5q MDS

Lenalidomide in Del 5q MDS
play_arrow
MDS: Low-Risk Disease Treatment Options

MDS: Low-Risk Disease Treatment Options
play_arrow
Neoadjuvant Treatment for Triple-Negative Breast Cancer

Neoadjuvant Treatment for Triple-Negative Breast Cancer
play_arrow
Dr. Coleman on the VELIA Trial Impact on Ovarian Cancer Practice

Dr. Coleman on the VELIA Trial Impact on Ovarian Cancer Practice
play_arrow
Dr. Tsao on Rationale for Staging Renal Cell Carcinoma

Dr. Tsao on Rationale for Staging Renal Cell Carcinoma
play_arrow
Cirrhosis Prognosis: The Child-Pugh Score

Cirrhosis Prognosis: The Child-Pugh Score
play_arrow
Dr. Tan on the Risk of Novel Coronavirus for Patients With Cancer

Dr. Tan on the Risk of Novel Coronavirus for Patients With Cancer
play_arrow
Dr. Corcoran on Targeting HER2 Amplification in CRC

Dr. Corcoran on Targeting HER2 Amplification in CRC